 Erin Baschal
Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Haplotypes | 9 | 2020 | 448 | 1.530 |
Why?
| | Scoliosis | 6 | 2021 | 179 | 1.470 |
Why?
| | Major Histocompatibility Complex | 5 | 2012 | 217 | 1.110 |
Why?
| | Diabetes Mellitus, Type 1 | 16 | 2023 | 3244 | 0.950 |
Why?
| | Polymorphism, Single Nucleotide | 10 | 2020 | 1879 | 0.830 |
Why?
| | HLA-DQ Antigens | 5 | 2018 | 174 | 0.800 |
Why?
| | Microtubules | 2 | 2018 | 237 | 0.750 |
Why?
| | HLA-DR Antigens | 5 | 2022 | 219 | 0.650 |
Why?
| | Extracellular Matrix | 3 | 2021 | 436 | 0.610 |
Why?
| | Polymorphism, Genetic | 4 | 2021 | 610 | 0.580 |
Why?
| | Actin Cytoskeleton | 1 | 2018 | 93 | 0.580 |
Why?
| | HLA-B Antigens | 3 | 2011 | 56 | 0.540 |
Why?
| | Alleles | 6 | 2022 | 789 | 0.520 |
Why?
| | Exome | 3 | 2018 | 200 | 0.510 |
Why?
| | Genetic Predisposition to Disease | 9 | 2021 | 2084 | 0.500 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2014 | 21 | 0.480 |
Why?
| | Genome, Human | 3 | 2012 | 347 | 0.480 |
Why?
| | HLA-DR3 Antigen | 2 | 2010 | 79 | 0.400 |
Why?
| | Genotyping Techniques | 1 | 2012 | 69 | 0.390 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2009 | 46 | 0.380 |
Why?
| | Genotype | 8 | 2011 | 1760 | 0.340 |
Why?
| | Pedigree | 5 | 2021 | 460 | 0.320 |
Why?
| | Otitis Media | 2 | 2021 | 142 | 0.310 |
Why?
| | Mutation, Missense | 2 | 2020 | 293 | 0.290 |
Why?
| | HLA-DP Antigens | 1 | 2007 | 32 | 0.280 |
Why?
| | Thiabendazole | 1 | 2006 | 1 | 0.280 |
Why?
| | Genes, cdc | 1 | 2006 | 10 | 0.270 |
Why?
| | Carbamates | 1 | 2006 | 34 | 0.270 |
Why?
| | HLA-DQ beta-Chains | 3 | 2020 | 57 | 0.260 |
Why?
| | Addison Disease | 3 | 2011 | 40 | 0.260 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2006 | 41 | 0.260 |
Why?
| | Schizosaccharomyces | 1 | 2006 | 53 | 0.260 |
Why?
| | Cytoplasm | 1 | 2006 | 255 | 0.260 |
Why?
| | Benzimidazoles | 1 | 2006 | 138 | 0.250 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 386 | 0.220 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 551 | 0.210 |
Why?
| | Multifactorial Inheritance | 2 | 2021 | 122 | 0.200 |
Why?
| | Gene Frequency | 4 | 2011 | 477 | 0.200 |
Why?
| | Islets of Langerhans | 2 | 2023 | 726 | 0.190 |
Why?
| | Insulin | 2 | 2008 | 2076 | 0.190 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.190 |
Why?
| | Linkage Disequilibrium | 3 | 2011 | 245 | 0.190 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2022 | 152 | 0.180 |
Why?
| | Steroid 21-Hydroxylase | 2 | 2011 | 30 | 0.180 |
Why?
| | Plasminogen | 1 | 2020 | 33 | 0.180 |
Why?
| | Genetic Variation | 2 | 2015 | 870 | 0.170 |
Why?
| | Cytoskeleton | 1 | 2021 | 176 | 0.170 |
Why?
| | Zebrafish | 2 | 2021 | 411 | 0.170 |
Why?
| | Humans | 27 | 2023 | 114623 | 0.170 |
Why?
| | Methyldopa | 1 | 2018 | 7 | 0.150 |
Why?
| | HLA-D Antigens | 2 | 2008 | 34 | 0.150 |
Why?
| | Cation Transport Proteins | 1 | 2018 | 123 | 0.150 |
Why?
| | Antigen Presentation | 1 | 2018 | 188 | 0.140 |
Why?
| | Influenza, Human | 1 | 2022 | 546 | 0.140 |
Why?
| | Antibody Formation | 1 | 2018 | 266 | 0.140 |
Why?
| | Melanoma | 1 | 2022 | 619 | 0.130 |
Why?
| | Autoantibodies | 4 | 2018 | 1345 | 0.130 |
Why?
| | Immunity, Cellular | 1 | 2018 | 248 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2021 | 1018 | 0.120 |
Why?
| | T-Lymphocytes | 2 | 2023 | 1736 | 0.120 |
Why?
| | Sequence Analysis | 1 | 2014 | 35 | 0.120 |
Why?
| | Genetic Association Studies | 2 | 2018 | 339 | 0.120 |
Why?
| | Male | 11 | 2022 | 55554 | 0.110 |
Why?
| | Child | 7 | 2022 | 18404 | 0.110 |
Why?
| | Autoimmunity | 2 | 2010 | 813 | 0.110 |
Why?
| | Algorithms | 2 | 2012 | 1466 | 0.110 |
Why?
| | HapMap Project | 1 | 2012 | 3 | 0.100 |
Why?
| | Chromosomes, Human | 1 | 2012 | 39 | 0.100 |
Why?
| | Telomere | 2 | 2011 | 202 | 0.100 |
Why?
| | Homozygote | 2 | 2009 | 187 | 0.100 |
Why?
| | Ubiquitins | 1 | 2011 | 31 | 0.100 |
Why?
| | Female | 11 | 2022 | 59466 | 0.090 |
Why?
| | Recombination, Genetic | 1 | 2012 | 176 | 0.090 |
Why?
| | Chromosome Mapping | 2 | 2009 | 487 | 0.090 |
Why?
| | Endocrine Cells | 1 | 2010 | 6 | 0.090 |
Why?
| | HLA Antigens | 1 | 2011 | 224 | 0.090 |
Why?
| | DNA Replication | 1 | 2011 | 202 | 0.090 |
Why?
| | Genetic Loci | 1 | 2011 | 262 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2023 | 615 | 0.080 |
Why?
| | HLA-A Antigens | 1 | 2009 | 49 | 0.080 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 723 | 0.080 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2009 | 172 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2009 | 218 | 0.080 |
Why?
| | Minisatellite Repeats | 1 | 2008 | 38 | 0.080 |
Why?
| | Heterozygote | 1 | 2009 | 251 | 0.080 |
Why?
| | Software | 1 | 2012 | 529 | 0.070 |
Why?
| | Base Sequence | 1 | 2011 | 2114 | 0.070 |
Why?
| | Survival | 1 | 2007 | 37 | 0.070 |
Why?
| | Nuclear Family | 1 | 2007 | 49 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2008 | 98 | 0.070 |
Why?
| | Histocompatibility Testing | 1 | 2007 | 116 | 0.070 |
Why?
| | Phenotype | 1 | 2014 | 2796 | 0.070 |
Why?
| | HLA-DP beta-Chains | 1 | 2007 | 76 | 0.070 |
Why?
| | Phleomycins | 1 | 2006 | 1 | 0.070 |
Why?
| | Drug Resistance, Fungal | 1 | 2006 | 9 | 0.070 |
Why?
| | Transformation, Genetic | 1 | 2006 | 15 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 2785 | 0.070 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2006 | 17 | 0.070 |
Why?
| | Logistic Models | 1 | 2011 | 1840 | 0.070 |
Why?
| | Chromosome Segregation | 1 | 2006 | 36 | 0.070 |
Why?
| | DNA, Fungal | 1 | 2006 | 69 | 0.070 |
Why?
| | Epistasis, Genetic | 1 | 2006 | 67 | 0.070 |
Why?
| | Spindle Apparatus | 1 | 2006 | 87 | 0.060 |
Why?
| | Cell Polarity | 1 | 2006 | 131 | 0.060 |
Why?
| | Morphogenesis | 1 | 2006 | 159 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1518 | 0.060 |
Why?
| | Actins | 1 | 2006 | 381 | 0.060 |
Why?
| | Cohort Studies | 2 | 2015 | 4894 | 0.060 |
Why?
| | DNA Damage | 1 | 2006 | 351 | 0.060 |
Why?
| | Protein Processing, Post-Translational | 1 | 2006 | 399 | 0.060 |
Why?
| | Risk Factors | 4 | 2009 | 8628 | 0.060 |
Why?
| | Infant | 4 | 2022 | 7959 | 0.060 |
Why?
| | Microbiota | 2 | 2021 | 647 | 0.060 |
Why?
| | Adult | 5 | 2018 | 30528 | 0.050 |
Why?
| | Animals | 6 | 2021 | 31694 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2006 | 430 | 0.050 |
Why?
| | Child, Preschool | 4 | 2021 | 9108 | 0.050 |
Why?
| | Phosphorylation | 1 | 2006 | 1569 | 0.050 |
Why?
| | Mice, Inbred NOD | 2 | 2018 | 555 | 0.050 |
Why?
| | Mice | 4 | 2021 | 14860 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 309 | 0.050 |
Why?
| | Mutation | 2 | 2021 | 3344 | 0.050 |
Why?
| | Ear, Middle | 1 | 2020 | 89 | 0.040 |
Why?
| | Cilia | 1 | 2021 | 162 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 439 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2021 | 305 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 187 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 485 | 0.040 |
Why?
| | Ions | 1 | 2018 | 59 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 848 | 0.040 |
Why?
| | Zebrafish Proteins | 1 | 2021 | 246 | 0.040 |
Why?
| | Risk Assessment | 1 | 2007 | 2967 | 0.040 |
Why?
| | Movement | 1 | 2018 | 244 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 591 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 725 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 635 | 0.030 |
Why?
| | Bone and Bones | 1 | 2018 | 278 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2022 | 3003 | 0.030 |
Why?
| | Kyphosis | 1 | 2015 | 33 | 0.030 |
Why?
| | Collagen | 1 | 2015 | 415 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2018 | 1947 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 4689 | 0.020 |
Why?
| | HLA-B15 Antigen | 1 | 2011 | 13 | 0.020 |
Why?
| | Adolescent | 3 | 2020 | 17831 | 0.020 |
Why?
| | HLA-B8 Antigen | 1 | 2010 | 14 | 0.020 |
Why?
| | Graves Disease | 1 | 2009 | 32 | 0.020 |
Why?
| | HLA-DRB1 Chains | 1 | 2009 | 98 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2010 | 372 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2009 | 136 | 0.020 |
Why?
| | Interferon-alpha | 1 | 2009 | 186 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2009 | 5043 | 0.020 |
Why?
| | Young Adult | 2 | 2015 | 10455 | 0.020 |
Why?
| | Middle Aged | 2 | 2022 | 26719 | 0.020 |
Why?
| | Risk | 1 | 2010 | 812 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 2010 | 382 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2008 | 168 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 993 | 0.020 |
Why?
| | Disease Progression | 1 | 2009 | 2380 | 0.010 |
Why?
| | Chronic Disease | 1 | 2008 | 1578 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 4405 | 0.010 |
Why?
| | Aged | 1 | 2009 | 19061 | 0.010 |
Why?
|
|
Baschal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|